NEW
ANTI-COAGULANT
•
Confidence with appropriate
patient selection
2, 3, 4
•
Rapid and consistent
platelet control
1
•
Greater continuous
protection
2
References:
1
.Payne CD,
et al
. J Cardiovasc Pharmacol 2007;50:555-562.
2
.Wiviott SD,
et al
. N Engl J Med 2007;357:2001-2015.
3
.Montalescot G,
et al
.
Lancet 2009;373(9665):723-731.
4
.Wiviott SD,
et al.
Circulation 2008;118:1626-1636.
S4
EFIENT
®
5 mg film coated tablets: each tablet contains 5 mg plasugrel (as hydrochloride). Reg. No.: 43/8.2/0242
S4
EFIENT
®
10 mg film coated tablets: each tablet contains 10 mg plasugrel (as hydrochloride). Reg. No.: 43/8.2/0243. EFIENT
®
5 mg and 10 mg
contains lactose.
For further information please refer to the package insert approved by the medicines regulatory authority. Eli Lilly (S.A.) (Pty) Ltd. Reg No.
1957/000371/07. 1 Petunia Street, Bryanston, 2021. Telephone: (011) 510 9300. A2609 (Feb 2011) 134293
Aspirin
EFIENT.
YOUR DECISION.
THEIR FUTURE.
MAKE A
BIGGER DIFFERENCE
WITH EFIENT
